Podcast episode 98 (in German)
The vagus nerve – the distance between surgery and an ear clip
October 6, 2026
A clip for the ear costs 49 euros and promises less stress and better sleep. The largest study ever conducted on this nerve missed its primary endpoint — and together the two make a more interesting picture than either number on its own.
What it is about
The vagus nerve is sold as a calming switch, but it is mainly a reporting line: around 80 percent of its fibers run from the body to the brain. That is precisely why stimulation works at all, because it sends a signal upward, to core regions for attention, mood and inflammation. This has turned into real medicine, with approved implanted devices. The episode takes apart the large depression study that clearly missed its prespecified endpoint, contrasts it with a small but properly blinded study in healthy people in which one measurement moved in the wrong direction — and explains why 139 studies in healthy people can still hardly be added up.
Key points
- About 80 percent of the vagus nerve’s fibers run upward, from the body to the brain — the supposed calming switch is four-fifths reporting line.
- An implanted device has been approved for severe epilepsy since 1997; treatment-resistant depression followed later, and in 2021 an approval for stroke patients.
- The RECOVER study randomized 493 adults over 12 months, double-blinded; the primary endpoint had a prespecified threshold of 0.023 and came in at 0.137.
- Several prespecified secondary endpoints were significant, including the clinician’s global impression at 0.004 — they are in the press release, the missed primary endpoint is not.
- In 28 healthy volunteers, after 7 days with 30 minutes of ear stimulation daily, maximal oxygen uptake rose by 3.8 percent and performance by 6 watts.
- In the same study, resting heart rate rose by 4 beats, that is, in the direction the calming model specifically does not predict.
- A review of 139 studies in healthy people counts 25 hertz for frequency alone in 100 papers, alongside 10, 20, 30 and 100 hertz.
Where the data stop
The settings are the core problem. For current intensity, 51 studies applied the rule of staying below the pain threshold, 19 a slight tingling, 28 a measured threshold; in the review’s own words, it remains unclear which parameters are most effective and when. Added to this is a finding that affects the whole literature: the same review reports that active and sham stimulation can affect cardiac activity similarly. On an ear full of nerve endings, a truly ineffective spot is hard to find.
The safety picture also looks better than the evidence supports: 41 studies explicitly reported no side effects, 13 described mild ones such as headache, tingling and fatigue — and 76 said nothing about it at all. That heart rate variability shifts in the short term through humming or slow exhalation is readily measurable; that health follows from it has not been shown. And the data on the implanted procedure do not transfer to a device on the ear.
Listen (in German)
Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music
Published on October 6, 2026.
The topic in the database
- Targeted stimulation of the vagus nerve (e.g. via an ear electrode): meant to strengthen the parasympathetic nervous system.Vagus nerve stimulation (active)
All episodes in the app (German)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-09-19.